Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats

Journal of Bone and Mineral Research

Volumn 12, Issue 2, 1997, Pages 267-275

  Ma, Yan Fei ^a   Lin, Bai Yun ^a,b   Jee, Webster S S ^a,e   Lin, Chao Hua ^a   Chen, Yong Yong ^a   Ke, Hua Zhu ^c   Li, Xiao Jian ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c PFIZER INC   (United States)

^d Genetics Institute Cambridge   (United States)

^e UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2; RISEDRONIC ACID; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; ETIDRONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; BONE STRENGTH; BONE TURNOVER; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; DRUG WITHDRAWAL; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; RAT; TIBIA; AGE; AGING; ANIMAL; BONE; BONE DENSITY; CHEMISTRY; CYTOLOGY; DRUG COMBINATION; DRUG POTENTIATION; FEMALE; NASA DISCIPLINE MUSCULOSKELETAL; NASA DISCIPLINE NUMBER 26-10; NASA PROGRAM SPACE PHYSIOLOGY AND COUNTERMEASURES; NON-NASA CENTER; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

NASA DISCIPLINE MUSCULOSKELETAL; NASA DISCIPLINE NUMBER 26-10; NASA PROGRAM SPACE PHYSIOLOGY AND COUNTERMEASURES; NON-NASA CENTER;

AGE FACTORS; AGING; ANIMALS; BONE AND BONES; BONE DENSITY; CALCIUM CHANNEL BLOCKERS; DINOPROSTONE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ETIDRONIC ACID; FEMALE; RATS; RATS, SPRAGUE-DAWLEY; TIBIA;

EID: 0031065460     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.2.267     Document Type: Article

References (32)

1. Ueda K, Saito A, Nakano H, Aoshima M, Muraoka R, Iwaya T 1980 Cortical hyperosteosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. J Pediatr 97: 834-836.
2. Ringel RW, Brenner JI, Henry PH, Burns JE, Moulton AL, Berman MA 1982 Prostaglandin induced periostitis: A complication of long-term PGE1 infusion in an infant with congenital heart disease. Radiology 142: 657-658.
3. Li XJ, Jee WSS, Li LY, Patterson-Buckendahl P 1990 Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs. Bone 11: 353-364.
4. High WB 1988 Effects of orally administered prostaglandin E2 on cortical bone turnover in adult dogs: A histomorphometric study. Bone 8: 363-373.
5. Shih M-S, Norrdin RW 1986 Effect of prostaglandins on regional remodeling changes during tibial healing in beagles: A histomorphometric study. Calcif Tissue Int 39: 191-197.
6. Shih M-S, Norrdin RW 1986 PGE2 induces regional remodeling changes in hacersian envelope: A histomorphometric study of fractured ribs in beagles. Bone Miner 1: 227-234.
7. 2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats. Bone 11:253-266.
8. 2 on tibial diaphyseal bone in male rats. Bone Miner 15:33-35.
9. Jee WSS, Ke HZ, Li XJ 1992 Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats. Bone Miner 17: 31-47.
10. Tang LY, Jee WSS, Ke HZ, Kimmel DB 1992 Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure. J Bone Miner Res 7: 1093-1104.
11. Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC 1993 Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J Bone Miner Res 8: 871-880.
12. 2 and Risedronate administration on cancellous bone in older female rats. Bone 15:489-496.
13. 2 and risedronate administration is maintained after their withdrawal in older female rats. J Bone Miner Res 10:963-970.
14. Wronski TJ, Yen C-F 1994 Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15: 51-58.
15. Baumann BD, Wronski TJ 1995 Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16: 247-253.
16. Pan Z, Jee WSS, Ma YF, McOsker JE, Li XJ 1995 Intermittent treatments of prostaglandin E2 plus risedronate and prostaglandin E2 alone are equally anabolic on tibial shaft of ovariectomized rats. Bone 17 (Suppl):291S-296S.
17. Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL 1990 Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res 5: 311-319.
18. Ma YF, Jee WSS, Chen YY, Gasser J, Ke HZ, Li XI, Kimmel DB 1995 Partial maintenance of extra cancellous bone mass by anti-resorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilization rats. J Bone Miner Res 10: 1726-1734.
19. Jee WSS, Inoue J, Jee KW, Haba T 1983 Histomorphometric assay of the growing long bone. In: H. Takahashi (ed.) Handbook of Bone Morphology. Nishimura Co., Ltd., Niigata City, Japan, pp. 101-122.
20. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphom- etry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2: 595-610.
21. Kimmel DB, Jee WSS 1980 A quantitative of the growing long bone metaphysis. Calcif Tissue Int 32: 113-122.
22. Jee WSS, Li XJ, Schaffler MB 1991 Adaptation of diaphyseal structure with aging and increased mechanical usage in the adult rat: A histomorphometrical and biomechanical study. Anat Rec 230: 332-338.
23. Schaffler MB, Burr DB, Jungers WL, Ruff CB 1985 Structural and mechanical indicators of limb specialization in primates. Folia Primatol 45: 61-75.
24. Neter J, Wasserman W, Whitmore GA 1982 Applied statistics. Allyn and Bacon, Boston, MA, U.S.A., pp. 544-572.
25. Smith ML, Fogelman I, Hart DM, Scott E, Bevan J and Leggate I 1989 Effect of etidronate disodium on bone turnover following surgical menopause. Calcif Tissue Int 44: 74-79.
26. Frost HM 1990 Skeletal structural adaptations to mechanical usage (SATMU). 1. Redefining Wolff's law: The bone modeling problem. Anat Rec 226: 403-413.
27. Matthews DE, Farewell VT 1985 Using and Understanding Medical Statistics. Karger, Basel, Switzerland, pp. 158-169.
28. Royce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF 1996 Effects of intermittent hPTH (1-34) alone and in combination with 1,25 (OH)2D3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11: 600-613.
29. High WB 1988 Effects of orally administration prostaglandin E-2 on cortical bone turnover in adult dogs: A histomorphometric study. Bone 8: 363-373.
30. Frost HM 1996 Introduction to a new skeletal physiology. Bone and Bone, Vol 1. Pajaro Group, Pueblo, CO, U.S.A. pp. 52-74.
31. 2 increased rat cortical bone mass when administered immediately following ovariectomy. Bone Miner 21:189-201.
32. Frost HM 1987 The mechanostat: A proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. Bone Miner 2: 73-85.